一个放射病学研究 ameloblastomas 的基因病学变体和它们的增殖指数
Chané Smit1, Liam Robinson1, Marlene B van Heerden1
1Department of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria, South Africa.
概括
这项研究分析了乳腺母细胞瘤 (ABs),发现与单囊变异相比,plexiform变异呈现出更高的增殖和攻击性特征,为瘤行为提供了洞察力.
科学领域:
- 口腔和面病理学 口腔和面病理学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 骨髓母细胞瘤 (ABs) 是一种具有多种基因病理变异的瘤.
- 了解变体之间的临床放射学和扩散差异对于治疗规划至关重要.
研究的目的:
- 为了研究临床放射学特征,Ki-67增殖指数和乳腺母细胞瘤的基因病学变体之间的关联.
- 为了区分 ameloblastoma 变种的生物行为.
主要方法:
- 分析了116例被证实为阴道病理学诊断的乳腺母细胞瘤病例.
- 组织样本上的Ki-67增殖指数的免疫组织化学.
- 评估人口统计学,临床和放射学特征,调查人员对变种和扩散指数视而不见.
主要成果:
- 单囊变体表现出低Ki-67指数,生长缓慢,皮质破坏较少,表明惰的行为.
- 形变体表现出高的Ki-67指数,与快速生长,疼痛和像皮质破坏这样的侵略性放射性特征相关.
- 在基-67,位置,边界,局部性和皮质破坏方面观察到变体之间的统计学上显著差异.
结论:
- 基-67增殖指数和临床放射学特征在乳腺母细胞瘤变体之间有显著差异.
- 这些差异为不同的生物行为和 ameloblastoma 亚型的攻击性提供了宝贵的见解.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...


